Disposables push Pall sales growth; Merck taps CMO Patheon for expanded services;

> Pall Life Sciences reports that third-quarter consumable sales to drugmakers grew 9 percent worldwide over third-quarter figures from a year ago, thanks in part to expanding adoption of single-use technologies. Item

> Contract manufacturer Patheon has expanded its services for Merck. Item

> Increased compliance requirements and pressure to achieve higher quality have resulted in new drug delivery options. Article

> ProximaRF and Phase IV Engineering have partnered to offer high-frequency RFID-enabled sensing products. Announcement

> Existing manufacturing facilities can be made smaller and more efficient by producing proteins in fermentors with Dyadic's C1 technology, a specialized fungus that can mass-produce enzymes and proteins. Article

Suggested Articles

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.